Open access · OA
via Europe PMC
Epigenetic aging in the tumor microenvironment: mechanisms and implications for immunotherapy.
Frontiers in aging · 2026
Epigenetic alterations
Cellular senescence
Chronic inflammation
Cell culture / in vitro
Human
Review
Abstract
Aging reshapes the tumor microenvironment (TME) by altering the immune, stromal, and vascular compartments, yet these changes are not fully explained by chronological age. Epigenetic mechanisms, including DNA methylation, histone modifications, chromatin accessibility, and non-coding RNA programs, may contribute to persistent alterations in cellular function and communication. In this review, we synthesize current evidence on epigenetic remodeling in the aged TME, distinguishing established findings in aging and cancer from mechanisms that remain to be demonstrated specifically in aged tumors. We highlight how epigenetic changes intersect with cellular senescence(definition), chronic inflammation, and metabolic stress to weaken antitumor immunity and influence treatment response, with particular attention to T-cell dysfunction, regulatory T-cells, myeloid cells, fibroblasts, and endothelial cells. We also discuss the limitations of bulk-tissue epigenetic clocks and the emerging value of cell-resolved and spatial analyses. Finally, we consider therapeutic implications, including epigenetic therapies, senescence-directed interventions, and selective targeting of suppressive immune-stromal interactions, while noting that their ability to reverse TME aging remains uncertain. Integrating longitudinal human studies with functional experiments will be essential to determine whether epigenetically altered immune-stromal niches can serve as biomarkers or therapeutic targets beyond chronological age alone.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fragi.2026.2008892
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
F, T., & Y., S. (2026). Epigenetic aging in the tumor microenvironment: mechanisms and implications for immunotherapy. <em>Frontiers in aging</em>. https://doi.org/10.3389/fragi.2026.2008892
Vancouver
F T, Y. S. Epigenetic aging in the tumor microenvironment: mechanisms and implications for immunotherapy. Frontiers in aging. 2026. doi:10.3389/fragi.2026.2008892.
BibTeX
@article{takezawa2026Epigen,
title = {Epigenetic aging in the tumor microenvironment: mechanisms and implications for immunotherapy.},
author = {Takezawa F and Sato Y.},
journal = {Frontiers in aging},
year = {2026},
doi = {10.3389/fragi.2026.2008892},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Immunologic research 2026
Citation only
Premature immune aging in obesity: a testable framework linking immunosenescence, metaflammation, and multiorgan dysfunction.
Journal of Taibah University Medical Sciences 2026
Open access · OA
Impact of aging on the tumor microenvironment in oral cancer: Mechanisms and therapeutic perspectives.
Frontiers in Immunology 2021
Open access · CC-BY
Targeting Aging: Lessons Learned From Immunometabolism and Cellular Senescence
Frontiers in pharmacology 2026
Open access · OA
Cellular senescence in ovarian cancer: a proposed geroncogenic shift linking aging, plasticity, and therapy resistance.
Frontiers in Pharmacology 2026
Open access · CC-BY
Cellular senescence in ovarian cancer: a proposed geroncogenic shift linking aging, plasticity, and therapy resistance
Frontiers in Immunology 2026
Open access · CC-BY